New Report Gives Projections for the Pharmaceutical and Healthcare Market in Poland to 2009
Posted on: Wednesday, 21 November 2007, 06:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c75023) has announced the addition of Pharmaceutical and Healthcare Market in Poland 2007 - Development Forecasts for 2007-2009 to their offering.
The latest report from us is Pharmaceutical and healthcare market in Poland 2007. It provides information covering the size of the drug market in Poland from 2002-2006 and projections for 2007-2009. Market shares of the key players are presented, as consortiums and as individual companies. Market size and analysis are also broken down to each drug category for easy referencing.
Insights into ongoing trends, growths and declines as well as insider analysis are also offered. Factors that influence the market, from epidemiology to consumer behaviour over the years, are studied and presented for your thorough understanding of the market. Economic data such as employment and cost-revenue analysis of the pharmaceutical sector are also covered.
Key sections
The report comprises two main sections:
Section I: Pharmaceutical market in Poland
- Overview of the pharmaceutical market in Poland
- Pharmacy market analysis according to ATC categories
- Analysis of the Polish pharmaceutical industry
- Rankings
- Key factors impacting the market
- Distribution of medicines in Poland
Section II: Healthcare market
An essential read for:
- top managers and strategic planners of pharmaceutical companies already operating or considering entering the Polish market;
- distributors of medicines: wholesalers, pharmacists, owners of pharmacy chains
- associations of pharmaceutical companies
- embassies, governmental agencies and chambers of commerce and industry
- financial institutions including banks, brokerage houses and investment funds
- legal and consulting companies involved in market research
This report is an invaluable resource for any company wanting to engage in or strengthen its position in the Polish pharmaceutical and healthcare market.
1. Report methodology
2. Executive summary
3. Overview of the pharmaceutical market in Poland
Key events and trends in 2006-2007
Key events and trends anticipated for 2007-2008
Size of the pharmaceutical market in Poland
- Size of the pharmacy market in 2002-2009
- Value of pharmacy sales in 2002-2006
- Development forecasts for 2007-2009
- Sales volume (number of packages)
- Domestic and foreign pharmaceuticals in 2002-2009
Drug prices
- Average drug prices in 2002-2007
- Percentage share of reimbursement in pharmacy trade
- Drug prices in Poland and in other European countries
- Average prices in therapeutic groups
- Changes relevant to drug prices in the draft amendment to the Pharmaceutical Law
Size of the hospital market in 2000-2009
4. Pharmacy market by therapeutic groups
The largest therapeutic categories of drugs on the pharmacy and Rx markets
- Largest by sales value
- Largest by sales volume
Cardiovascular system
- Market size and forecasts
- Key ATC subcategories of drugs used in cardiovascular diseases
- Best selling preparations
Alimentary tract and metabolism
- Market size and forecasts
- Key ATC subcategories of drugs used in alimentary tract and metabolic diseases
- Best selling preparations
Central nervous system
- Market size and forecasts
- Key ATC subcategories of drugs used in central nervous system diseases
- Best selling preparations
Respiratory system
- Market size and forecasts
- Key ATC subcategories of drugs used in respiratory system diseases
- Best selling preparations
Anti-infectives
- Market size and forecasts
- Key ACT subcategories of anti-infectives
- Best selling preparations
Musculo-skeletal system
- Market size and forecasts
- Key ATC subcategories of drugs used in musculo-skeletal diseases
- Best selling preparations
Genito-urinary system
- Market size and forecasts
- Key ATC subcategories of drugs used in genito-urinary system diseases
- Best selling preparations
Dermatologicals
- Market size and forecasts
- Key ATC subcategories of dermatologicals
- Best selling preparations
Blood and blood forming organs
- Market size and forecasts
- Key ATC subcategories of drugs used in diseases of the blood and blood forming organs
- Best selling preparations
Antineoplastic and immunomodulating agents
- Market size and forecasts
- Key ATC subcategories of antineoplastic and immunomodulating agents
Other ATC groups
- Sensory organs
- Systemic hormonal preparations
- Parasitology
- Various
5. Pharmaceutical companies in Poland
Number and classification of pharmaceutical manufacturers in Poland
- Manufacturers of pharmaceutical substances
- Drug manufacturers
Economic analysis of Polish pharmaceutical sector
- Output of selected pharmaceutical products
- Revenues
- Profit
- Operating expenses
- Employment
Investments in the Polish pharmaceutical industry in 2006
- Number of investments
- Investment outlays
- Outlays on intangible fixed assets
Foreign trade
- Export
- Imports
Ranking of the largest drug manufacturers
- Key players on the pharmacy market
- Key players on the Rx drug market
Profiles of top 10 players on the pharmaceutical market
- GlaxoSmithKline (GSK)
- Novartis
- Polpharma
- Servier
- Sanofi-Aventis
- Krka
- Roche
- Adamed
- Pliva (Barr group)
- Novo Nordisk
6. Factors influencing the pharmaceutical market in Poland
Demographic trends
- Population
- Population growth
- Ageing of society
- Live expectancy
- Main causes of death
Epidemiological trends
- The main health problems of Poles
- Epidemiology of selected diseases in Polish society
- Subjective assessment of ones health
Consumer behaviour
- Attitude towards non-European drugs
- Attitude towards generics
- Factors with a bearing on drug purchase decisions
- Sources of information on diseases and treatment
- Actions taken to stay healthy
- Image of pharmaceutical companies
Economic trends
Regulatory environment
- Regulations and institutions governing the pharmaceutical market in Poland
- Key changes introduced by the large amendment to the Pharmaceutical Law
- Key changes introduced by the small amendment to the Pharmaceutical Law
- Harmonisation of registration documents 160
- URPL President Act
- Third amendment to the Pharmaceutical Law
- Changes in rules governing parallel import
- Key amendments to the Healthcare Act
7. Distribution
Key players on the drug distribution market
Pharmaceutical wholesalers
- The largest players on the Polish wholesale market
- Wholesalers in Poland: number and business profiles
- Key events and trends on the wholesale market in 2006 and 2007
- Trends expected on the wholesale market in 2007 and 2008
Pharmacy distribution
- Pharmacies: number
- Pharmacies: financial standing
- Pharmacy chains
8. Healthcare market in Poland
Market of private medical services in Poland
- Market size
- Basic data on the market of private medical services
- Development forecasts
Basic data on healthcare system in Poland
9. List of graphs
10. List of tables
For more information visit http://www.researchandmarkets.com/reports/c75023
Source: Business Wire
Related Articles
- TRX Market Share & Forecast, 4th Edition, 2007-2012: A Comprehensive Analysis of the Global TRX Market By OEM and Unit Shipments
- The Worldwide Flat Panel Displays Industry: Market Perspective, Key Players and Forecasts to 2010
- ''Q3 Mobile Forecast: United States, 2007 - 2010 Report''- 65 Operational and Financial Metrics for the United States Wireless Market
- Research and Markets: Antibiotics and Drug Resistance 2007 - Drug Innovation and the Strategy to Combat Antibiotic Resistance Mechanisms
- Demand Still Outpaces Supply for Pinot Noir and for Dry White Wine States New Report 'Northern Hemisphere Grape Supply and Wine Production (Selected Regions) - Forecasts to 2011: 2007 Edition'
- Research and Markets: Ten Key Trends In Functional Foods 2007 Is A Practical Tool, Setting Out The Effect The Key Trends Will Have On Companies Such As Tesco, Coca-Cola And Yoplait's Strategies
- Alnylam Announces Key Product and Business Goals for 2007
- Inyx's Ashton Pharmaceuticals Selected to Produce Generic Drugs for European Markets
- The Current Mature Market for Hormonal Contraceptives and Infertility Drugs
- Research and Markets: The Current Mature Market for Hormonal Contraceptives and Infertility Drugs is Estimated at Us$7.1 Billion but is Forecast to Increase 40% to Us$9.9 Billion By 2012
User Comments (0)

RSS Feeds